Tag Archives for: IShares NASDAQ Biotechnology Index (ETF)(NASDAQ:IBB)
Visit our full IBB ticker page for ratings, quotes, and much more »

Here’s What’s Pushing Biotech Further Than Ever Before

From Franklin Templeton Investments: Franklin Equity Group’s Evan McCulloch explains why higher rates of drug utilization and health care spending are lending support to the biotechnology and health care industries. He also gives his take on recent medical breakthroughs he
Read more ›
NASDAQ:IBB September 26, 2018 6:11am

Biotech Presents Another Interesting Opportunity (IBB)

From Contrarian Outlook: Today I want to show you a beaten-down sector that has a long history of crushing the market–and 4 funds that should be on your radar now.
NASDAQ:IBB April 20, 2018 6:39am

What’s The Best Biotech ETF To Buy Right Now? (IBB)

From Zacks: The biotech sector has been attracting a lot of investor attention lately. This sector is expected to continue benefiting from increased M&A activities, new drug approvals, better R&D and innovations.
NASDAQ:IBB March 2, 2018 6:03am

Biotech Is Back In A Major Way (IBB)

From Dana Lyons: Left for dead after a bubbly blowoff in 2015, biotech stocks have finally clawed their way back to new highs.
NASDAQ:IBB January 13, 2018 5:04am

Can Biotech ETFs Continue Their Impressive Run In 2018? (IBB)

From Zacks: So far, it’s been a good year for biotech stocks with the Nasdaq Biotechnology Index soaring 19.6% year to date.
NASDAQ:IBB November 14, 2017 7:09am

Outflows Start To Hit The iShares NASDAQ Biotech ETF (IBB)

Analyst/ETF Trader Paul Weisbruch of Street One Financial brings us his daily fund flows update, which today examines a relatively muted ETF landscape that’s seen smallish outflows in biotech and some renewed interest in volatility products ahead of earnings season.
NASDAQ:IBB October 24, 2017 11:46am

Biotech Was The Hottest ETF Sector In The Third Quarter (IBB)

From Zacks: The broader market was pretty eventful in the third quarter. While geopolitical and political concerns were rife, those threats couldn’t weigh on the equity market returns.
NASDAQ:IBB October 3, 2017 10:09am

Positive Biotech Sentiment Takes Hold (IBB)

From Buzz Indexes: A common question we field relates to the transmission mechanism of sentiment to the share price: “How long does it take / when will it be reflected?”
NASDAQ:IBB July 6, 2017 2:58pm

More Gains Ahead For The Biotech ETF (IBB)?

From Dana Lyons: Last fall, we laid out the foundation for the current rally in pharmaceutical and biotech stocks; we take stock of those setups and the sectors’ present prospects.
NASDAQ:IBB June 29, 2017 8:55am

iShares NASDAQ Biotechnology Index ETF (IBB) Suddenly Looks Bullish

It has been some time since we last spoke about the Biotech Equity segment in this piece, as the sector was simply not a solid performer through much of 2016 and has only recently come to life here in mid-2017.
NASDAQ:IBB June 26, 2017 11:50am

Analyst: Buy Biotech (IBB) On The Next Pullback

From David Dutkewych: Three weeks ago, I wrote about money pouring into U.S. stocks, specifically technology stocks. Now, just three weeks later, the high-flying tech sector is writing a different story.
NASDAQ:IBB June 23, 2017 6:51am

What’s Next For Biotech Stocks? (IBB)

From Franklin Templeton Investments: Changing political policies and priorities can impact certain market sectors—for better or worse. Health care costs and prescription drug pricing were hot-button issues in the United States during the 2016 presidential election, and the Trump administration
Read more ›
NASDAQ:IBB June 7, 2017 5:57am

Free Investing Ideas Newsletter!

Join over 70,000 investors who get the latest insights and top rated picks from our free investment newsletter.

From Our Partners

7 Best ETFs for the NEXT Bull Market

Most Popular



Explore More from ETFDailyNews.com

Free Investment Newsletter

Join over 70,000 investors who get the latest insights and top rated picks from our free investment newsletter.

ETFDailyNews.com respects your privacy.

Best ETFs

We've rated and ranked nearly 2,000 ETFs and ETNs using our proprietary SMART Grade system.

View Top Rated ETFs

Best Categories

We've ranked dozens of ETF categories based on relative performance.

Best ETF Categories